OSM‑mediated STAT3/PDL1 promotes tumor progression and immune escape in colorectal cancer

Despite considerable progress in the clinical management of colorectal cancer (CRC), immune evasion remains a persistent challenge. Oncostatin M (OSM) expression and immune cell infiltration in CRC was first characterized using publicly available databases and clinical specimens. CRC cell lines with OSM overexpression were then established and their tumor‑promoting functions were assessed via in vitro proliferation, migration and wound healing assays. Subsequently, bulk RNA sequencing coupled with bioinformatic analysis was performed on human CRC cell lines, complemented by single cell RNA sequencing in a C57BL/6 mouse model. Subsequently, expression‑based ligand‑receptor analysis was used to investigate bidirectional communication between tumor and myeloid cells. Finally, flow cytometry and western blotting were subsequently used to evaluate programmed cell death 1 ligand 1 (PD‑L1) expression, T‑cell‑associated exhaustion markers, STAT3 phosphorylation, and the effects of pharmacological STAT3 inhibition. It was demonstrated that OSM expression was elevated in CRC tissues, and public‑dataset analysis associated higher OSM expression with poorer overall survival. OSM overexpression enhanced proliferative and migratory phenotypes in HCT116 and RKO cells. Single‑cell analysis revealed changes in the relative abundance of tumor, stromal and immune‑cell populations following OSM overexpression. Ligand‑receptor analysis further identified selective remodeling of bidirectional tumor‑myeloid communication, including increased predicted SPP1‑, MIF‑, CCL‑, TWEAK‑ and OSM‑associated signaling. OSM‑OSMR/IL6ST communication was detected in both tumor‑to‑myeloid and myeloid‑to‑tumor directions in the OSM‑overexpressing (OE) group. OSM overexpression was also associated with increased PD‑L1 expression, enhanced STAT3 phosphorylation, reduced CD8+ T‑cell representation, and increased PD‑1 and TIM‑3 expression in the analyzed tumor sample. In separate short‑term Stattic‑treated experiments, STAT3 inhibition remained lower STAT3 phosphorylation in OSM‑OE CRC cells. In conclusion, OSM overexpression is associated with enhanced malignant phenotypes, selective remodeling of tumor‑myeloid communication, and activation of STAT3/PD‑L1‑related signaling in CRC. These findings support an OSM‑associated model of tumor microenvironment remodeling and immune regulation, while further functional and molecular studies are required to establish the causal contribution of individual myeloid subsets and the direct dependence of PD‑L1 induction on STAT3.

Authors

Institutions

Publication Details

Journal
International Journal of Oncology
Published
2026-11-16
DOI
https://doi.org/10.3892/ijo.2026.5961
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

OSM‑mediated STAT3/PDL1 promotes tumor progression and immune escape in colorectal cancer

Bo Tang, Hongchao Zhen, Yuanchao Shi, Cao Bangwei et al.
1 links
International Journal of Oncology
Cancer Immunotherapy and Biomarkers
article

OSM‑mediated STAT3/PDL1 promotes tumor progression and immune escape in colorectal cancer

Bo Tang, Hongchao Zhen, Yuanchao Shi, Cao Bangwei, Jingwei Duan, Haishan Lin, 汪泽兴
article en

Abstract

Despite considerable progress in the clinical management of colorectal cancer (CRC), immune evasion remains a persistent challenge. Oncostatin M (OSM) expression and immune cell infiltration in CRC was first characterized using publicly available databases and clinical specimens. CRC cell lines with OSM overexpression were then established and their tumor‑promoting functions were assessed via in vitro proliferation, migration and wound healing assays. Subsequently, bulk RNA sequencing coupled with bioinformatic analysis was performed on human CRC cell lines, complemented by single cell RNA sequencing in a C57BL/6 mouse model. Subsequently, expression‑based ligand‑receptor analysis was used to investigate bidirectional communication between tumor and myeloid cells. Finally, flow cytometry and western blotting were subsequently used to evaluate programmed cell death 1 ligand 1 (PD‑L1) expression, T‑cell‑associated exhaustion markers, STAT3 phosphorylation, and the effects of pharmacological STAT3 inhibition. It was demonstrated that OSM expression was elevated in CRC tissues, and public‑dataset analysis associated higher OSM expression with poorer overall survival. OSM overexpression enhanced proliferative and migratory phenotypes in HCT116 and RKO cells. Single‑cell analysis revealed changes in the relative abundance of tumor, stromal and immune‑cell populations following OSM overexpression. Ligand‑receptor analysis further identified selective remodeling of bidirectional tumor‑myeloid communication, including increased predicted SPP1‑, MIF‑, CCL‑, TWEAK‑ and OSM‑associated signaling. OSM‑OSMR/IL6ST communication was detected in both tumor‑to‑myeloid and myeloid‑to‑tumor directions in the OSM‑overexpressing (OE) group. OSM overexpression was also associated with increased PD‑L1 expression, enhanced STAT3 phosphorylation, reduced CD8+ T‑cell representation, and increased PD‑1 and TIM‑3 expression in the analyzed tumor sample. In separate short‑term Stattic‑treated experiments, STAT3 inhibition remained lower STAT3 phosphorylation in OSM‑OE CRC cells. In conclusion, OSM overexpression is associated with enhanced malignant phenotypes, selective remodeling of tumor‑myeloid communication, and activation of STAT3/PD‑L1‑related signaling in CRC. These findings support an OSM‑associated model of tumor microenvironment remodeling and immune regulation, while further functional and molecular studies are required to establish the causal contribution of individual myeloid subsets and the direct dependence of PD‑L1 induction on STAT3.

International Journal of OncologyVol. 69(6)
Army Medical University (CN), Chongqing University (CN), Capital Medical University (CN), Beijing Friendship Hospital (CN)
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon